Davern Capital Partners, LP

SEC CIK: 0002003147
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

RPRX holding history

Royalty Pharma plc in every 13F filed by Davern Capital Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overview All 13F holders of RPRX Full Q2 2026 holdings

Shares (Q2 2026): 1,155,809
Value: $64.8M
% of portfolio: 11.0%
Quarters held: 3; Since Q4 2025

Holdings of RPRX by Davern Capital Partners, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,155,809	$64.8M	11.0%	+635,800+122.3%	Added	Holders
Q1 2026	520,009	$24.9M	6.8%	−320,641−38.1%	Reduced	Holders
Q4 2025	840,650	$32.5M	10.5%	–	No prior filing	Holders